Abstract: Provided are an NLP-based method for constructing a variant literature interpretation knowledge base, an interpretation method, and an electronic device. The method for constructing the variant literature interpretation knowledge base includes: obtaining disease-related literature; constructing, based on the disease-related literature, a database of entities associated with genes and variants; constructing a literature evidence knowledge graph for interpretation of variant literature; and performing evidence extraction on the literature evidence knowledge graph to obtain evidence corresponding to an entity, and constructing, based on the evidence and the database, the variant literature interpretation knowledge base. In this way, the literature evidences can be more comprehensive and systematic.

Abstract: Embodiments of this application relate to the field of communications technologies, and disclose a flow control method and apparatus, to resolve a prior-art problem such as packet loss, packet accumulation, or network congestion that occurs after a packet is switched between priority queues. A specific solution is as follows: A first device receives a first packet sent by a second device, where the first packet carries a first field and a second field, the first field carries a first priority, and the second field carries a second priority; the first device performs flow control based on the first priority in the first packet; and the first device performs queue scheduling on the first packet based on the second priority in the first packet.

Abstract: An isolated and purified nucleic acid molecule that encodes a polypeptide comprising at least eight contiguous amino acids of SEQ ID NO: 1, 2, or 3, wherein the at least eight contiguous amino acids have anti-viral activity, as well as an isolated and purified nucleic acid molecule that encodes a polypeptide comprising at least eight contiguous amino acids of SEQ ID NO: 1, 2, or 3, wherein the at least eight contiguous amino acids have anti-viral activity, a vector comprising such an isolated and purified nucleic acid molecule, a host cell comprising the nucleic acid molecule, optionally in the form of a vector, a method of producing an antiviral polypeptide or conjugate thereof, the anti-viral polypeptide itself, a conjugate or fusion protein comprising the anti-viral polypeptide, and compositions comprising an effective amount of the anti-viral polypeptide or conjugate or fusion protein thereof. Further provided are methods of inhibiting prophylactically or therapeutically a viral infection of a host.

Abstract: Embodiments of this application relate to the field of communications technologies, and disclose a flow control method and apparatus, to resolve a prior-art problem such as packet loss, packet accumulation, or network congestion that occurs after a packet is switched between priority queues. A specific solution is as follows: A first device receives a first packet sent by a second device, where the first packet carries a first field and a second field, the first field carries a first priority, and the second field carries a second priority; the first device performs flow control based on the first priority in the first packet; and the first device performs queue scheduling on the first packet based on the second priority in the first packet.

Abstract: The present invention provides a base station deployment configuration method. The method includes: receiving, by a base station after being powered on for a first time, a virtual local area network identity and composite information, receiving, by the base station, a plurality of ping packets, and learning, by the base station, the received virtual local area network identity in the service packet and virtual local area network identities in all the received ping packets; traversing, by the base station, the learned virtual local area network identities, and sending a DHCP request to a DHCP server; receiving, by the base station, a DHCP response message returned by the DHCP server; and establishing, by the base station, an OM IP address connection to a management channel of the wireless network manager according to the OM IP address, and receiving a complete configuration delivered through the management channel.

Abstract: An isolated and purified nucleic acid molecule that encodes a polypeptide comprising at least eight contiguous amino acids of SEQ ID NO: 1, 2, or 3, wherein the at least eight contiguous amino acids have anti-viral activity, as well as an isolated and purified nucleic acid molecule that encodes a polypeptide comprising at least eight contiguous amino acids of SEQ ID NO: 1, 2, or 3, wherein the at least eight contiguous amino acids have anti-viral activity, a vector comprising such an isolated and purified nucleic acid molecule, a host cell comprising the nucleic acid molecule, optionally in the form of a vector, a method of producing an antiviral polypeptide or conjugate thereof, the anti-viral polypeptide itself, a conjugate or fusion protein comprising the anti-viral polypeptide, and compositions comprising an effective amount of the anti-viral polypeptide or conjugate or fusion protein thereof. Further provided are methods of inhibiting prophylactically or therapeutically a viral infection of a host.

Abstract: The present invention provides a base station deployment configuration method. The method includes: receiving, by a base station after being powered on for a first time, a virtual local area network identity and composite information, receiving, by the base station, a plurality of ping packets, and learning, by the base station, the received virtual local area network identity in the service packet and virtual local area network identities in all the received ping packets; traversing, by the base station, the learned virtual local area network identities, and sending a DHCP request to a DHCP server; receiving, by the base station, a DHCP response message returned by the DHCP server; and establishing, by the base station, an OM IP address connection to a management channel of the wireless network manager according to the OM IP address, and receiving a complete configuration delivered through the management channel.

Abstract: A scytovirin domain 1 (SD1) polypeptide, a nucleic acid encoding the polypeptide, and related fusion proteins, conjugates, isolated cells, vectors, and antibodies, as well as a method of inhibiting a viral infection using the same.

Abstract: A scytovirin domain 1 (SD1) polypeptide, a nucleic acid encoding the polypeptide, and related fusion proteins, conjugates, isolated cells, vectors, and antibodies, as well as a method of inhibiting a viral infection using the same.

Abstract: A scytovirin domain 1 (SD1) polypeptide, a nucleic acid encoding the polypeptide, and related fusion proteins, conjugates, isolated cells, vectors, and antibodies, as well as a method of inhibiting a viral infection using the same.

Abstract: A scytovirin domain 1 (SD1) polypeptide, a nucleic acid encoding the polypeptide, and related fusion proteins, conjugates, isolated cells, vectors, and antibodies, as well as a method of inhibiting a viral infection using the same.

Abstract: A process for controlling the formation of TiO2 particles in a multi-stage vapor-phase oxidation reactor wherein the process includes the steps of limiting the fraction of TiCl4 converted into TiO2 in the reaction stream of a first or intermediate stage of the reactor under conditions that control the mean residence time distribution of the reacting mass. By running the reaction in this manner, the growth of TiO2 particles produced is so controlled that after subsequent standard finishing steps (e.g. milling) the fraction of particles having an average size of less than 0.5 &mgr;m is reduced or minimized.